ArticleCardiovascular engineering and technology2026
A Translational Paradigm for Univentricular Heart Disease: Single-Stage Neonatal Repair with Adaptive Control of Cavopulmonary Flow.
Article in Cardiovascular engineering and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUniventricular heart defects remain one of the greatest challenges in pediatric cardiovascular surgery. Although well-established, the traditional approach consisting of three serial palliative procedures (Norwood, Glenn, and Fontan) entails cumulative risks, repeated hospitalizations, high healthcare costs, and significant psychosocial impact. This study proposes a single-stage neonatal surgical strategy integrating a tissue-engineered vascular graft and a differential flow control valve to enable adaptive and gradual modulation of cavopulmonary flow, avoiding abrupt physiological transitions. To evaluate the hemodynamic feasibility of the proposed concept, a three-dimensional computational fluid dynamics model was developed and analyzed under controlled flow conditions.
methodsA three-dimensional model of the total cavopulmonary connection was developed to evaluate the hemodynamic feasibility of the surgical proposal. The fenestration diameter was reduced from 14 to 0 mm, representing progressive hemodynamic conditions. Computational fluid dynamics simulations were conducted under standardized physiological conditions, with neonatal pulmonary vascular resistance represented by porous zones. Flow distributions, pressure gradients, and hemodynamic equilibrium points were evaluated.
resultsProgressive reduction of fenestration diameter from 14 to 0 mm promoted gradual redistribution of venous flow from predominant right atrial diversion to predominant pulmonary perfusion. Systemic venous pressure increased from 4.2 to 10.6 mmHg as fenestration diameter decreased. An intermediate functional range between 5 and 6 mm provided a balanced distribution between pulmonary perfusion and right atrial diversion, consistent with an intermediate cavopulmonary flow condition.
conclusionWithin the assumptions of this proof-of-concept computational model, the proposed strategy demonstrated hemodynamic feasibility for progressive cavopulmonary flow modulation. By integrating tissue engineering, adaptive flow control, and computational modeling, the proposed concept provides a foundation for future patient-specific, experimental, and translational investigations in the treatment of univentricular heart defects.
Indexed as
Identifiers
42613553What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.